Regeneron week: AERIFY-1 COPD results posted; new cenvacibart, alirocumab, cemiplimab trials filedOct 16Weekly roundup, 6 itemsalirocumabcemiplimab-rwlcUpdated
Regeneron registers Phase 1b hemodialysis study, Phase 1 Graves' disease trialOct 9Weekly roundup, 6 itemsamrecibartbortezomib
Sanofi's itepekimab COPD mechanism study AERIFY-3 posts results after 2025 completionAug 31Trial updateitepekimabRegeneron Pharmaceuticals